Cover Image
市場調查報告書

全球靜脈注射用鐵劑市場

Global Intravenous (IV) Iron Drugs Market: Industry Analysis & Outlook 2017-2021

出版商 Koncept Analytics 商品編碼 230700
出版日期 內容資訊 英文 64 Pages
訂單完成後即時交付
價格
Back to Top
全球靜脈注射用鐵劑市場 Global Intravenous (IV) Iron Drugs Market: Industry Analysis & Outlook 2017-2021
出版日期: 2017年05月17日 內容資訊: 英文 64 Pages
簡介

本報告提供全球靜脈注射用鐵劑市場相關調查分析,以各地區的市場趨勢為焦點,提供概要,市場動態,競爭情形,主要企業簡介等系統性資訊。

第1章 人體的鐵分:簡介

  • 靜脈注射用鐵劑的適用領域
  • 鐵分不足:貧血
  • 貧血治療的靜脈注射療法
  • 靜脈注射用鐵劑的種類

第2章 全球鐵劑產品市場分析

  • 市場:各金額
  • 市場佔有率:各市場區隔

第3章 全球靜脈注射用鐵劑市場分析

  • 市場:各金額
  • 市場:各產品
  • 市場佔有率:各產品

第4章 地區的靜脈注射用鐵劑市場分析

  • 歐洲
  • 美國

第5章 市場動態

  • 成長推動因素
  • 趨勢
  • 課題

第6章 競爭情形

  • 產品比較

第7章 企業簡介

第8章 市場預測

  • 市場預測
  • 預測手法

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Iron is among the vital minerals present in the human body. It is one of the components of hemoglobin, the substance present in red blood cells that carries oxygen throughout the body through blood, and oxygen is further utilized by the cells to produce energy required to perform all the required functions. Therefore, decline in the body's supply of iron can lead to severe problems. The balance of iron in the body primarily is a combined result of three dynamics- intake, losses and metabolic demand.

Intravenous (I.V.) treatment, in a broad sense, covers all the types of medications delivered intravenously, i.e. directly into the vein, through intravenous (I.V.) drip. Compared to the other routes of infusing medications, the intravenous route is the fastest way to deliver fluids and medications throughout the body. Also, this method ensures 100% bioavailability, which means that the chemicals delivered are fully absorbed by the body.

The report “Global I.V. Iron Drugs Market” provides a comprehensive study of iron product market and I.V. iron market globally. It also provides detailed information for key regional markets of I.V iron industry. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry, Galenica Group, AMAG Pharmaceuticals and Allergan are being profiled. All these companies have been profiled in the present report highlighting their key financials and business strategies for growth.

The key factors driving the growth of I.V. iron drugs market are growing ageing population, growing urbanization, increase in number of dialysis cases, rising healthcare expenditure and increasing life expectancy rate. Some of the noteworthy trends and developments of this industry are paradigm shift from oral iron drugs to intravenous iron drugs and introduction of first generation drugs InFeD and Dexeferrum. However, the expansion of the market is hindered by potential risks of I.V. iron.

Table of Contents

1. I.V. Iron Market - An Overview

  • 1.1. Iron in Human Body: An Introduction
  • 1.2. I.V. Iron Application Areas
  • 1.3. I.V. Iron Applications in Nephrology
  • 1.4. Iron Deficiency - Anemia
  • 1.5. Iron Therapies for Anemia Treatment

2. Global Iron Product Market Analysis

  • 2.1. Global Iron Product Market by Value
  • 2.2. Global Iron Product Market Forecast by Value
  • 2.3. Global Iron Product Market by Segments
<>3. Global I.V. Iron Drugs Market Analysis
  • 3.1. Global I.V. Iron Drugs Market by Value
  • 3.2. Global I.V. Iron Drugs Market Forecast by Value
  • 3.3. Global I.V. Iron Drugs Market by Product Category
  • 3.4. Global I.V. Iron Drugs Market Share by Product Category
  • 3.5. Global I.V. Iron Drugs Market Share by Segments

4. Regional Market Analysis

  • 4.1. The US
    • 4.1.1. The US I.V. Iron Drug Market by Value
    • 4.1.2. The US I.V. Iron Drug Market Forecast by Value
    • 4.1.2. The US I.V. Iron Drug Market by Product Category
    • 4.1.3. The US I.V. Iron Drug Market Share by Product Category
    • 4.1.4. The US Non-dialysis I.V. Iron Drug Market by Volume
    • 4.1.5. The US Non-dialysis I.V. Iron Drug Market Forecast by Volume
    • 4.1.6. The US Non-dialysis I.V. Iron Drug Market Share by Product
  • 4.2. Europe
    • 4.2.1. European I.V. Iron Drug Market by Value
    • 4.2.2. European I.V. Iron Drug Market Forecast by Value
    • 4.2.3. European I.V. Iron Drug Market by Product Category
    • 4.2.4. European I.V. Iron Drug Market Share by Product Category

5. Market Dynamics

  • 5.1. Growth Drivers
    • 5.1.1. Growing Ageing Population
    • 5.1.2. Growing Urbanization
    • 5.1.3. Increase in Number of Dialysis Cases
    • 5.1.4. Rising Healthcare Expenditure
    • 5.1.5. Increasing Life Expectancy Rate
  • 5.2. Market Trends
    • 5.2.1. Paradigm Shift from Oral Iron Drugs to Intravenous Iron Drugs
    • 5.2.2. Introduction of First Generation Drugs InFeD and Dexeferrum
  • 5.3. Challenges
    • 5.3.1. Potential Risks of I.V. Iron

6. Competitive Landscape

  • 6.1. Comparison between Injectafer, Venofer, INFeD and Feraheme

7. Company Profiles

  • 7.1. Galenica Group
    • 7.1.1. Business Overview
    • 7.1.2. Financial Overview
    • 7.1.3. Business Strategies
  • 7.2. AMAG Pharmaceuticals
    • 7.2.1. Business Overview
    • 7.2.2. Financial Overview
    • 7.2.3. Business Strategies
  • 7.3. Allergan plc.
    • 7.3.1. Business Overview
    • 7.3.2. Financial Overview
    • 7.3.3. Business Strategies

List of Charts

  • Risk Factors for CKD
  • Global Iron Product Market by Value (2011-2016)
  • Global Iron Product Market Forecast by Value (2017-2021)
  • Global Iron Product Market by Segments (2016)
  • Global I.V. Iron Drugs Market by Value (2010-2016)
  • Global I.V. Iron Drugs Market Forecast by Value (2017-2021)
  • Global I.V. Iron Drugs Market by Product Category (2010-2016)
  • Global I.V. Iron Drugs Market Share by Product Category (2016)
  • Global I.V. Iron Drugs Market Share by Segments (2016)
  • The US I.V. Iron Drug Market by Value (2010-2016)
  • The US I.V. Iron Drug Market Forecast by Value (2017-2021)
  • The US I.V. Iron Drug Market by Product Category (2010-2016)
  • The US I.V. Iron Drug Market Share by Product Category (2016)
  • The US Non-dialysis I.V. Iron Drug Market by Volume (2010-2016)
  • The US Non-dialysis I.V. Iron Drug Market Forecast by Volume (2010-2016)
  • The US Non-dialysis I.V. Iron Drug Market Share by Product (2016)
  • European I.V. Iron Drug Market by Value (2010-2016)
  • European I.V. Iron Drug Market Forecast by Value (2017-2021)
  • European I.V. Iron Drug Market by Product Category (2010-2016)
  • European I.V. Iron Drug Market Share by Product Category (2016)
  • Global Ageing Population (2007-2016)
  • Global Urban Population (2007-2016)
  • Global Dialysis Patients (2012-2016)
  • Global Dialysis Patients by Type (2016)
  • Global Healthcare Expenditure (2007-2016)
  • Global Life Expectancy Rate (2007-2016)
  • Comparison between Injectafer, Venofer, INFeD and Feraheme
  • Galenica's Net Sales Share by Business Segments (2016)
  • Galenica's Net Sales Share by Region (2016)
  • Galenica's Net Sales and Net Profit (2012-2016)
  • AMAG Pharmaceuticals' Revenue and Net Income (2012-2016)
  • Allergan Plc.'s Revenue Business Segment (2016)
  • Allergan Plc.'s Revenue and Net Income (2012-2016)
Back to Top